Shares of Olink Holding AB (publ) (NASDAQ:OLK – Get Free Report) have received a consensus rating of “Hold” from the six brokerages that are covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $25.20.
OLK has been the subject of several analyst reports. Morgan Stanley upped their target price on Olink Holding AB (publ) from $18.00 to $26.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 24th. Leerink Partnrs downgraded Olink Holding AB (publ) from an “outperform” rating to a “market perform” rating in a research report on Tuesday, October 17th. Finally, Scotiabank reissued a “sector perform” rating on shares of Olink Holding AB (publ) in a report on Wednesday, October 18th.
View Our Latest Stock Report on Olink Holding AB (publ)
Institutional Inflows and Outflows
Olink Holding AB (publ) Trading Up 0.4 %
Shares of OLK stock opened at $24.84 on Monday. The company has a current ratio of 7.41, a quick ratio of 5.84 and a debt-to-equity ratio of 0.01. Olink Holding AB has a twelve month low of $14.10 and a twelve month high of $26.47. The company has a market capitalization of $3.09 billion, a P/E ratio of -177.42 and a beta of 0.60. The business’s 50 day moving average is $18.76 and its two-hundred day moving average is $18.81.
About Olink Holding AB (publ)
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.
Featured Stories
- Five stocks we like better than Olink Holding AB (publ)
- How to Invest in Small Cap Stocks
- MarketBeat Week in Review – 11/6 – 11/10
- How to Use the MarketBeat Dividend Calculator
- Data giants MongoDB and Snowflake just got upgraded
- The Most Important Warren Buffett Stock for Investors: His Own
- Plug Power at tipping point; it’s make or break time for hydrogen
Receive News & Ratings for Olink Holding AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olink Holding AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.